{"schema_version":"secwatch.filing_event.v1","accession":"0001412408-22-000049","form_type":"8-K","ticker":"PHR","cik":"0001412408","company_name":"Phreesia, Inc.","filed_at":"2022-09-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.666605+00:00","generated_at":"2026-06-23T14:01:09.719628+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Phreesia Q2 FY2023 revenue $67.9M (+33% YoY); raises FY revenue and EBITDA guidance","bullets":["Revenue $67.9M, up 33% YoY; average healthcare clients 2,776 (+40% YoY).","Adjusted EBITDA loss widened to $26.0M from $11.0M in prior year.","FY2023 revenue guidance raised to $273M-$275M; Adj. EBITDA guidance improved to negative $106M-$109M.","Cash $240.7M, down $73.1M from Jan; expects $165M-$170M by Jan 31, 2023.","Average revenue per healthcare client $18,248, down 7% YoY as client growth outpaced payment volume."],"urls":{"canonical":"https://secwatch.observer/filing/0001412408-22-000049","json":"https://secwatch.observer/filing/0001412408-22-000049.json","markdown":"https://secwatch.observer/filing/0001412408-22-000049.md","text":"https://secwatch.observer/filing/0001412408-22-000049.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1412408/000141240822000049/0001412408-22-000049-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1412408/000141240822000049/phr-20220907.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T14:01:09.719628+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}